Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.

Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).

Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.

[Exercise stress test and dobutamine stress echocardiography for the prognostic stratification after uncomplicated acute myocardial infarction].

Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.

Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.

Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system.

Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.

Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.

[Risk stratification after acute myocardial infarction: limitations of dobutamine stress echocardiography in females].

Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.

Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.

[Infusion of flecainide in a patient with atrial fibrillation and latent Brugada's syndrome has determined modifications of the electrocardiogram similar to those of a septal myocardial infarct].

Detecting blunt pancreatic injuries.